February, 2003
© 2000, 2001, 2003 Scott S. Emerson, M.D., Ph.D.
In cancer less than 5% of treatments studied in clinical
trials are adopted
NCI drug development program 1970 - 1985
·350,000 unique chemical structures studied
·83 pass preclinical and phase I testing
·24 pass phase II tests for biological activity